Swaza – Strategic-Technological Analysis (Poland)
15 pages · PDF · 23 September 2025 · Licensed single-user copy, watermarked to the buyer
€299 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment
One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).
About this report
Swaza is a deep-tech biotechnology startup that has developed a novel oxygen delivery platform with applications in both civilian healthcare and military performance enhancement . Its flagship therapy, SWAZA-1, is a non-invasive nanofluid breathing aid designed to oxygenate damaged lung tissue (described as carrying “20x concentration of oxygen” relative to lung fluid ).
This technology sits at the intersection of battlefield medicine and civilian emergency care. In this analysis, we examine Swaza’s technology and strategy through the lens of European defense objectives.
Key questions this report answers
- What is Swaza's SWAZA-1 non-invasive nanofluid breathing aid, and how does it oxygenate damaged lung tissue?
- How does Swaza's oxygen-delivery platform bridge battlefield medicine and civilian emergency care, and how mature is it?
- What partnerships and market strategy support Swaza's dual-use development?
- What capability gaps and strategic indicators define Swaza's relevance to European defence medicine?
Inside this report
- Executive Summary
- 1. Corporate Identity & Legal Structure
- 2. Strategic Business Profile
- 3. Technology Portfolio Mapping
- 4. Technology Readiness Assessment
- 5. European Strategic Program Participation
- 6. Academic & Research Origins
- 7. Dual-Use Applications & European Market Strategy
- 8. Strategic Partnerships & European Industrial Alliances
- 9. European Market Focus & Operational Domains
- 10. Intellectual Property & European Innovation Assets
- 11. Leadership & European Technical Expertise
- 12. Capability and Gap Analysis
- 13. Strategic Indicators & European Innovation Metrics
Who it's for
Investors screening Swaza, competitors and partners assessing their position, and analysts who need a sourced, structured account of the entity and its technology.
Related reports
Methodology, format & delivery
DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; it reflects them as of its publication date (23 September 2025). You receive a 15-page PDF, watermarked to you on every page, delivered on the confirmation page and by e-mail immediately after checkout (personal link valid 72 hours, up to 5 downloads). Guest checkout, single-user licence — Terms of Sale.
Related on DFM
More Tactical reports · Military Medical Tech · Human Enhancement · Free summary of this report · All reports
Prefer unlimited access?
Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →